Epperlein, S.; Gebhardt, C.; Rohde, K.; Chakaroun, R.; Patt, M.; Schamarek, I.; Kralisch, S.; Heiker, J.T.; Scholz, M.; Stumvoll, M.;
et al. The Effect of FGF21 and Its Genetic Variants on Food and Drug Cravings, Adipokines and Metabolic Traits. Biomedicines 2021, 9, 345.
https://doi.org/10.3390/biomedicines9040345
AMA Style
Epperlein S, Gebhardt C, Rohde K, Chakaroun R, Patt M, Schamarek I, Kralisch S, Heiker JT, Scholz M, Stumvoll M,
et al. The Effect of FGF21 and Its Genetic Variants on Food and Drug Cravings, Adipokines and Metabolic Traits. Biomedicines. 2021; 9(4):345.
https://doi.org/10.3390/biomedicines9040345
Chicago/Turabian Style
Epperlein, Sarah, Claudia Gebhardt, Kerstin Rohde, Rima Chakaroun, Marie Patt, Imke Schamarek, Susan Kralisch, John T. Heiker, Markus Scholz, Michael Stumvoll,
and et al. 2021. "The Effect of FGF21 and Its Genetic Variants on Food and Drug Cravings, Adipokines and Metabolic Traits" Biomedicines 9, no. 4: 345.
https://doi.org/10.3390/biomedicines9040345
APA Style
Epperlein, S., Gebhardt, C., Rohde, K., Chakaroun, R., Patt, M., Schamarek, I., Kralisch, S., Heiker, J. T., Scholz, M., Stumvoll, M., Kovacs, P., Breitfeld, J., & Tönjes, A.
(2021). The Effect of FGF21 and Its Genetic Variants on Food and Drug Cravings, Adipokines and Metabolic Traits. Biomedicines, 9(4), 345.
https://doi.org/10.3390/biomedicines9040345